Variable | Portugal (n= 120) | Australia (n= 89) |
---|---|---|
Male/Female, n (%) | 87 (72.5)/33 (27.5) | 64 (71.9)/25 (28.1) |
Age, years, mean (SD) | 55.9 (21.1) | 40.0 (18.9) |
APACHE II, mean (SD) | 17.2 (6.1) | 18.2 (7.4) |
Diagnosis, n (%) | ||
Trauma | 56 (46.7) | 40 (44.9) |
Sepsis | 38 (31.7) | 39 (43.8) |
Respiratory failure (without sepsis) | 13 (10.8) | 2 (2.2) |
Post-operative (without sepsis) | 7 (5.8) | 3 (3.4) |
Other | 6 (5.0) | 5 (5.6) |
ARC Subgroup ( n = 86) | ||
Male/Female, n (%) | 66 (76.7)/20 (23.3) | |
Age, years, median (IQR) | 35 (25-51.2) | |
Weight, kg, median (IQR) | 80 (70-90) | |
Height, m, median (IQR) | 1.7 (1.68-1.76) | |
BSA, m2, median (IQR) | 1.93 (1.81-2.07) | |
APACHE II, mean (SD) | 14.8 (5.8) | |
SIRS (on day of study), n (%) | 86 (100) | |
Septic (on day of study), n (%) | 65 (75.6) | |
Mechanical ventilation (on day of study), n (%) | 83 (96.5) | |
Vasoactive drugs (on day of study), n (%) | 24 (27.9) | |
Diuretic (on day of study), n (%) | 35 (40.7) | |
Fluid balance (on day of study), ml, mean (SD) | 311 (1640) | |
Serum creatinine, mg/dl (μmol/l), median (IQR) | 0.7 (0.6-0.9) (62 (53-80)) | |
Measured CLCR, ml/min/1.73 m2, median (IQR) | 162 (145-190) |